Gladstone Institutional Advisory’s Galectin Therapeutics GALT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$52K	Hold	24,650	–	–	﹤0.01%	748
2025 Q1	$30.1K	Hold	24,650	–	–	﹤0.01%	713
2024 Q4	$31.8K	Buy	24,650 +2,900	+13%	+$3.74K	﹤0.01%	695
2024 Q3	$59.8K	Buy	+21,750	New	+$59.8K	﹤0.01%	674